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Abstract – Optically active γ-lactams were prepared by asymmetric 
dicarbonylation reaction of N-arylsulfonyl homoallylic amines catalyzed by 
palladium in the presence of copper(I) triflate. By the use of benzyl-substituted 
bioxazoline ligand, the corresponding γ-lactams were obtained with 
enantioselectivities of up to 67% ee. 
INTRODUCTION 
The γ-lactams are widespread among biologically active natural and non-natural products and have 
therefore been used as a privileged structural subunit for the design of several pharmaceutical agents. In 
addition, they also serve as important intermediates for the synthesis of nitrogen-containing molecules.1 
Among many synthetic approaches developed for γ-lactams, those using the transition-metal catalysts are 
of high value since they generally allow efficient and selective production of functionalized γ-lactams 
under mild reaction conditions.2 Chemoselective formation of γ-lactams via intramolecular C-H 
amidation of 1,4,2-dioxazol-5-ones is a straightforward way to furnish γ-lactams.3 Transition-metal 
catalyzed cyclocarbonylation of amine derivatives with CO via C-H bond activation is an attractive 
method to directly introduce a carbonyl group.4 Furthermore, aminocarbonylation to a carbon-carbon 
double bond is a promising alternative.5 Until recently, the development of enantioselective 
intramolecular aminocarbonylation has remained limited.3b,5d,e Previously, as part of our program aimed 
at the development of palladium-catalyzed carbonylation reactions, we discovered asymmetric 
bis(alkoxycarbonylation) of homoallylic alcohols via cyclocarbonylation/alkoxycarbonylation to produce 
 
the corresponding optically active γ-lactones.6 In this paper, we will describe synthesis of γ-lactams by 
asymmetric dicarbonylation of N-arylsulfonyl homoallylic amine derivatives catalyzed by palladium in 
the presence of a copper salt. 
RESULTS AND DISCUSSION 
Based on our previous study on dicarbonylation of homoallylic amine derivatives, N-tosyl homoallylic 
amine 1a possessing a cyclohexane skeleton was chosen as the substrate.7 Thus, 1a was treated with a 
0.02 equiv. of PdCl2 and a 0.5 equiv. of CuOTf(C6H6)0.5 under normal pressure of CO and O2 (ca. 1/1, 
v/v) using (4S,4'S)-4,4'-dibenzyl-4,4',5,5'-tetrahydro-2,2'-bioxazole (L1) as a chiral ligand in MeOH/THF 
at 60 °C.8 To our delight, the desired doubly carbonyl-incorporated γ-lactam 2a was obtained in 53% 
yield.9 The optical purity of 2a was determined to be 67% ee by HPLC analysis (Table 1, Entry 1). The 
effect of substituents at the 4- and 4'-positions in the bioxazoline ligands was investigated. 
Dicarbonylation using aliphatic substituted ligands L2 and L3 gave disappointing results (Entries 2 and 3). 
 
Table 1. Asymmetric dicarbonylation reaction of 1a using various ligands 
 
Entry Ligand Yield/%  ee/%a 
1  L1 53  67 
2  L2 31   2 
3  L3 41  34 
4   L4b 62 –49 
5  L5 30  60 
6  L6 51  47 
7   L7b 57 –53 
8  L8 47  30 
9  L9 44  –9 
aEnantioselectivities were determined by HPLC analysis 















L1: R = CH2Ph
L2: R = i-Pr
L3: R = i-Bu
L4: R = Ph
L6: R = CH2(1-Nap)
L7: R = CH2(2-Nap)













The phenyl-substituted bioxazoline ligand L4 was effective (Entry 4). The aromatic fused ligand L5 
induced relatively good enantiodifferentiation (Entry 5). In the case of naphtyl-substituted benzyl-type 
ligands L6 and L7, the γ-lactam 2a was obtained with moderate enatioselectivities (Entries 6 and 7). The 
bioxazoline ligand L8 with hydroxy groups was examined, but the enantioselectivity was not improved 
(Entry 8). The use of the bis(oxazoline) ligand L9 was unpromising, giving the product with poor 
enantioselectivity (Entry 9). Overall, among all tested ligands, benzyl-substituted bioxazoline L1 
appeared to be the most effective ligand for the intra- and intermolecular dicarbonylation reaction of 
N-tosyl homoallylic amine 1a. 
Next, the asymmetric dicarbonylation reactions using other solvents and various substrates were 
investigated as shown in Table 2. When the asymmetric dicarbonylation reactions of 1a in EtOH and 
i-PrOH with THF instead of MeOH were examined, the corresponding ethyl ester 2aE and isopropyl ester 
2aP were obtained with lower enantioselectivities, respectively. Therefore, all the following reactions 
were examined in MeOH/THF.  
The asymmetric dicarbonylation reactions of several N-arylsulfonyl homoallylic amines by the use of 
PdCl2 and CuOTf(C6H6)0.5 under CO and O2 (ca. 1/1, v/v) were carried out. 
N-(4-Methoxyphenyl)sulfonyl homoallylic amine 1b was applicable to this reaction, giving the product 
2b with 51% ee. γ-Lactam formation of sterically demanding N-(2,4,6-triisopropylphenyl)sulfonyl 
homoallylic amine 1c proceeded rather cleanly to produce the product 2c in 85% yield with 50% ee. 
Reactions of electron-withdrawing p-bromo and p-nitrosubstituted N-arylsulfonyl substrates 1d and 1e 
gave the corresponding γ-lactams 2d and 2e with 25% ee and 46% ee, respectively. In the case of 
N-α-naphthylsulfonyl and N-β-naphthylsulfonyl substituted homoallylic amines 1f and 1g, the 
corresponding γ-lactams 2f and 2g were obtained with enantioselectivities of 42% ee and 51% ee, 
respectively. After all, most of N-arylsulfonyl homoallylic amine derivatives afforded the corresponding 
γ-lactams with about 50% ee. 
Finally, the asymmetric dicarbonylation reactions of several N-tosyl homoallylic amines with substituents 
other than cyclohexane backbone were carried out. Dicarbonylation reactions of the substrates possessing 
cyclopentane and cycloheptane ring moieties 1h and 1i were sluggish and the γ-lactams 2h and 2i were 
obtained in poor yields. Unfortunately, simple non-substituted N-tosyl 3-butenylamine was not applicable 
to the reaction and the desired product was not obtained (not shown). The dicarbonylation reaction of the 
dimethyl-substituted homoallylic amine derivative 1j afforded the corresponding γ-lactam 2j in 55% ee. 
In the case of diphenyl-substituted substrate 1k, intra- and intermolecular dicarbonylation proceeded to 




Table 2. Asymmetric dicarbonylation reaction of N-arylsulfonyl homoallylic amines 1a,b 
 
aReaction times were shown in Experimental section. bEnantioselectivities were determined by 














2a; 53%, 67% ee







2d; 51%, 25% ee
2e; 50%, 46% ee
CO/O2 (ca. 1/1)


















































2h; 17%, 38% ee
 
The absolute configuration of 2a was determined to be S by X-ray crystallographic analysis of a single 
crystal (CCDC-1889364): the Flack parameter was 0.017(4). The absolute configurations of other 
products were tentatively determined to be S as well. 
Because of the coincidence in the absolute configuration between 2a and the product of dicarbonylation 
reaction from 1-allylcyclohexanol using ligand L1 previously reported,6a we propose that the mechanism 
of the present reaction is identical to that of the dicarbonylation of homoallylic alcohols, which has been 
proved to include the syn-insertion of an alkene moiety to a Pd-carbonyl bond.6b In both reactions, the 
stereochemical outcomes can be explained by the similar models T1 and T2 (Figure 1).6a That is, steric 
hindrance between a benzyl group in L1 and the substituent R in the N-tosyl homoallylic amines in 1 
would disfavor the transition state T2, and the second carbonyl insertion from T1 proceeds in syn-fashion 
to furnish (S)-γ-lactam mainly. 
 
Figure 1. Proposed stereochemical models for dicarbonylation 
 
In conclusion, we have developed a palladium-catalyzed asymmetric dicarbonylation reaction of 
N-arylsulfonyl homoallylic amines to form the optically active (methoxycalbonyl)methyl 
group-substituted γ-lactams with enantioselectivities of up to 67% ee. This represents a new synthetic 
method for the rapid construction of optically active γ-lactams, which are important scaffolds for 
biologically relevant molecules. 
EXPERIMENTAL 
1H NMR spectroscopy was performed in CDCl3 using a JEOL ECS 400 NMR (400 MHz) spectrometer. 
Chemical shifts (δ) were determined relative to TMS (δ = 0 ppm) as an internal standard. 13C NMR 
spectroscopy was performed in CDCl3 on a JEOL ECS 400 NMR (100 MHz) spectrometer and chemical 
shifts (δ) were determined relative to CDCl3 (δ = 77.0 ppm) as an internal standard. IR spectra were 
acquired on a JASCO FT/IR-230 spectrometer. Melting points were determined on a micro-melting 
apparatus (As One) and were uncorrected. The MS spectra were recorded with JEOL JMS-T100TD and 































spherical neutral (37563-84), and JAIGL-SIL (s-043-15) were used for thin-layer chromatography (TLC), 
flash column chromatography, and recycle HPLC, respectively. 
Representative Procedure for the Asymmetric Dicarbonylation Reaction of 1a (Table 2): Under an 
Ar atmosphere, PdCl2 (1.1 mg, 0.006 mmol), CuOTf(C6H6)0.5 (37.8 mg, 0.15 mmol), benzyl-substituted 
bioxazoline ligand L1 (3.8 mg, 0.012 mmol) were placed in a flask. Next, a solution of 
N-(1-allylcyclohexyl)-4-methylbenzenesulfonamide (1a) (92.8 mg, 0.3 mmol) in MeOH (3 mL) and THF 
(3 mL) were added. The Ar atmosphere was replaced with CO/O2 (ca. 1/1, v/v) and the reaction mixture 
was stirred for 5 d at 60 °C. A saturated aq solution of NaHCO3 was added to the reaction mixture at rt, 
and the insoluble substance was filtered off through Celite. After the filtrate was extracted three times 
with AcOEt, the combined organic layers were washed with water and brine, and dried over Na2SO4. The 
solvent was evaporated and the residue was separated by preparative TLC on silicagel (hexane/AcOEt = 
2/1) to give γ-lactam 2a (60.4 mg, 53%). 
(S)-Methyl 2-(2-oxo-1-tosyl-1-azaspiro[4.5]decan-3-yl)acetate (2a)7: Reaction time was 5 d. A solid. 
Mp 141−142 °C. [α]D25 −1 (c 0.6, CHCl3). The ee was determined to be 67% by HPLC (Daicel 
CHIRALCEL OJ-H, hexane/EtOH = 10/1, 0.75 mL/min, 220 nm, major 35 min, minor 77 min). 1H NMR 
(400 MHz, CDCl3): δ 1.24−1.49 (m, 4H), 1.66−1.85 (m, 5H), 2.33 (dd, J = 16.9, 8.7 Hz, 1H), 2.42 (s, 3H), 
2.44−2.51 (m, 1H), 2.67 (dd, J = 12.4, 9.2 Hz, 1H), 2.80 (dd, J = 16.9, 4.1 Hz, 1H), 2.85−2.91 (m, 2H), 
3.65 (s, 3H), 7.30 (d, J = 8.2 Hz, 2H), 7.93 (d, J = 8.2 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 21.6, 22.8, 
24.1, 24.5, 33.5, 34.3, 36.6, 36.8, 37.8, 51.9, 69.7, 128.5, 129.2, 136.6, 144.6, 171.7, 174.7. IR (KBr): 
2938, 2867, 1722, 1596, 1442, 1363, 1343, 1260, 1215, 1161, 1089, 1066, 998, 882, 826, 683, 657 cm−1. 
Enantiomerically pure 2a was obtained by recrystallization procedure: First recrystallization of 2a (ca 
40% ee) from EtOH gave the solid 2a with lower optical purity. Condensation of the filtrate furnished 2a 
with higher optical purity (87% ee). The recrystallization of the latter gave the solid and the filtrate. The 
filtrate was condensed and recrystallized again. Then almost optically pure 2a (99.7% ee) was recovered 
from its filtrate. Finally recrystallization of the sample from EtOH afforded the single crystal. Crystal 
data: C19H25NO5S, Mr = 379.46, monoclinic, P21, a = 10.0472(3), b = 15.6733(5), c = 11.8531(3) Å, β = 
96.148(1). V = 1855.81(9) Å3, Z = 4, Dcalcd = 1.358 g cm−3, R = 0.0413 (Rw = 0.1380) for 6784 reflections, 
Flack parameter = 0.017(4). Crystallographic data reported in this manuscript have been deposited with 
Cambridge Crystallographic Data Centre as deposition number CCDC-1889364. Free copies of the data 
can be obtained via http://www.ccdc.cam.ac.uk/conts/retrieving.html. 
In a similar manner, other γ-lactams 2aE, 2aP, and 2b−2k were prepared from the corresponding 
N-arylsulfonyl homoallylic amines 1a−1k. 
Ethyl 2-(2-oxo-1-tosyl-1-azaspiro[4.5]decan-3-yl)acetate (2aE): Reaction time was 5 d. A solid. Mp 
116–117 °C. [α]D25 –2 (c 1.3, CHCl3). The ee was determined to be 38% by HPLC (Daicel CHIRALPAK 
 
IB, hexane/EtOH = 20/1, 0.5 mL/min, 220 nm, major 49 min, minor 51 min). 1H NMR (400 MHz, 
CDCl3): δ 1.21 (t, J = 7.3 Hz, 3H), 1.23–1.52 (m, 4H), 1.23–1.52 (m, 5H), 2.32 (dd, J = 16.5, 8.7 Hz, 1H), 
2.42 (s, 3H), 2.42–2.53 (m, 1H), 2.67 (dd, J = 12.9, 6.9 Hz, 1H), 2.77–2.94 (m, 3H), 4.10 (q, J = 7.3 Hz, 
2H), 7.30 (d, J = 8.7 Hz, 2H), 7.93 (d, J = 8.7 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 14.1, 21.6, 22.8, 
24.1, 24.5, 33.5, 34.5, 36.6, 36.8, 37.8, 60.8, 69.7, 128.5, 129.2, 136.7, 144.5, 171.2, 174.7. IR (KBr): 
2980, 2938, 2969, 1947, 1716, 1595, 1455, 1382, 1364, 1345, 1305, 1262, 1215, 1152, 1066, 1029, 983, 
884, 825, 682, 656 cm–1. HRMS (DART) m/z: Calcd for C20H28NO5S [M+H]+: 394.1688, Found: 
394.1688. 
Isopropyl 2-(2-oxo-1-tosyl-1-azaspiro[4.5]decan-3-yl)acetate (2aP): Reaction time was 3 d. An oil. 
[α]D25 −4 (c 0.3, CHCl3). The ee was determined to be 40% by HPLC (Daicel CHIRALPAK IB, 
hexane/EtOH = 20/1, 0.2 mL/min, 230 nm, major 95 min, minor 98 min). 1H NMR (400 MHz, CDCl3): δ 
1.18 (d, J = 6.4 Hz, 6H), 1.22–1.50 (m, 4H), 1.62–1.88 (m, 5H), 2.29 (dd, J = 17.0, 9.2 Hz, 1H), 2.42 (s, 
3H), 2.41–2.52 (m, 1H), 2.66 (dd, J = 12.4, 9.2 Hz, 1H), 2.75 (dd, J = 17.0, 3.7 Hz, 1H), 2.79–2.93 (m, 
2H), 4.93–5.02 (m, 1H), 7.30 (d, J = 8.7 Hz, 2H), 7.93 (d, J = 8.7 Hz, 2H). 13C NMR (100 MHz, CDCl3): 
δ 21.6, 21.69, 21.73, 22.9, 24.1, 24.5, 33.5, 34.8, 36.6, 36.8, 37.9, 68.3, 69.7, 128.6, 129.2, 136.7, 144.5, 
170.7, 174.7. IR (KBr): 2934, 2867, 1721, 1597, 1496, 1452, 1364, 1343, 1298, 1225, 1157, 1109, 1075, 
1011, 957, 906, 812, 769, 684, 658 cm–1. HRMS (DART) m/z: Calcd for C21H30NO5S [M+H]+: 408.1845, 
Found: 408.1851. 
Methyl 2-(1-((4-methoxyphenyl)sulfonyl)-2-oxo-1-azaspiro[4.5]decan-3-yl)acetate (2b): Reaction 
time was 4 d. A solid. Mp 151–152 °C. [α]D25 +1 (c 0.4, EtOH). The ee was determined to be 51% by 
HPLC (Daicel CHIRALCEL OJ-H, hexane/EtOH = 4/1, 0.75 mL/min, 240 nm, major 26 min, minor 66 
min). 1H NMR (400 MHz, CDCl3): δ 1.21–1.48 (m, 4H), 1.66–1.84 (m, 5H), 2.33 (dd, J = 16.9, 8.2 Hz, 
1H), 2.42–2.52 (m, 1H), 2.66 (dd, J = 12.4, 10.1 Hz, 1H), 2.77–2.92 (m, 3H), 3.64 (s, 3H), 3.86 (s, 3H), 
6.96 (d, J = 8.7 Hz, 2H), 7.97 (d, J = 8.7 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 22.8, 24.0, 24.5, 33.4, 
34.3, 36.6, 36.7, 37.8, 51.9, 55.6, 69.6, 113.7, 130.8, 131.1, 163.5, 171.7, 174.6. IR (KBr): 2988, 2946, 
2861, 1721, 1595, 1498, 1453, 1367, 1344, 1330, 1261, 1162, 1072, 1021, 838, 730, 662 cm–1. HRMS 
(DART) m/z: Calcd for C19H26NO6S [M+H]+: 396.1481, Found: 396.1474. 
Methyl 2-(2-oxo-1-((2,4,6-triisopropylphenyl)sulfonyl)-1-azaspiro[4.5]decan-3-yl)acetate (2c): 
Reaction time was 4 d. An oil. [α]D25 −6 (c 1.3, EtOH). The ee was determined to be 50% by HPLC 
(Daicel CHIRALCEL OJ-H, hexane/i-PrOH = 50/1, 0.5 mL/min, 240 nm, major 25 min, minor 27 min). 
1H NMR (400 MHz, CDCl3): δ 1.12–1.48 (m, 24H), 1.54–1.88 (m, 4H), 2,14–2.24 (m, 1H), 2.40–2.50 (m, 
1H), 2.58–2.90 (m, 3H), 3.57 (s, 3H), 4.10–4.20 (m, 3H), 7.07 (s, 2H). 13C NMR (100 MHz, CDCl3): δ 
23.0, 23.3, 23.4, 24.1, 24.2, 24.4, 24.5, 24.7, 28.7, 33.3, 34.0, 34.7, 36.5, 36.8, 37.5, 51.8, 60.3, 71.0, 
123.7, 128.2, 133.6, 151.2, 153.4, 171.7, 175.1. IR (KBr): 2955, 2868, 2359, 1730, 1601, 1462, 1362, 
 
1327, 1151, 1060, 988, 881, 658 cm–1. HRMS (DART) m/z: Calcd for C27H42NO5S [M+H]+: 492.2784, 
Found: 492.2797. 
Methyl 2-(1-((4-bromophenyl)sulfonyl)-2-oxo-1-azaspiro[4.5]decan-3-yl)acetate (2d): Reaction time 
was 4 d. A solid. Mp 122–123 °C. [α]D25 −2 (c 0.5, CHCl3). The ee was determined to be ee was 
determined to be 25% by HPLC (Daicel CHIRALCEL OJ-H, hexane/EtOH = 4/1, 1.0 mL/min, 230 nm, 
major 13 min, minor 25 min). 1H NMR (400 MHz, CDCl3): δ 1.21–1.57 (m, 4H), 1.66–1.94 (m, 5H), 2.34 
(dd, J = 17.4, 8.7 Hz, 1H), 2.38－2.50 (m, 1H), 2.67 (dd, J = 12.8, 9.6 Hz, 1H), 2.78 (dd, J = 17.4, 4.1 Hz, 
1H), 2.82–2.93 (m, 2H), 3.65 (s, 3H), 7.65 (d, J = 8.7 Hz, 2H), 7.92 (d, J = 8.7 Hz, 2H). 13C NMR (100 
MHz, CDCl3): δ 22.8, 24.0, 24.5, 33.6, 34.1, 36.4, 36.7, 37.7, 51.9, 70.0, 128.8, 130.0, 131.9, 138.5, 
171.5, 174.8. IR (KBr): 2944, 2867, 1727, 1574, 1443, 1366, 1347, 1300, 1160, 1068, 1011, 970, 823, 
763, 702 cm–1. HRMS (DART) m/z: Calcd for C18H23BrNO5S [M+H]+: 444.0480, Found: 444.0477. 
Methyl 2-(1-((4-nitrophenyl)sulfonyl)-2-oxo-1-azaspiro[4.5]decan-3-yl)acetate (2e): Reaction time 
was 4 d. A solid. Mp 176–179 °C. [α]D25 −1 (c 0.4, CHCl3). The ee was determined to be 46% by HPLC 
(Daicel CHIRALCEL OJ-H, hexane/EtOH = 4/1, 0.5 mL/min, 254 nm, major 85 min, minor 116 min). 1H 
NMR (400 MHz, CDCl3): δ 1.18–1.48 (m, 4H), 1.58–1.84 (m, 5H), 2.22–2.42 (m, 2H), 2.58–2.84 (m, 
3H), 3.57 (s, 3H), 8.18 (d, J = 7.8 Hz, 2H), 8.28 (d, J = 7.8 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 22.8, 
24.0, 24.4, 33.8, 33.9, 36.3, 36.6, 37.6, 52.0, 70.4, 123.9, 129.9, 144.9, 150.4, 171.4, 175.1. IR (KBr): 
2928, 2859, 1730, 1607, 1530, 1439, 1357, 1296, 1228, 1178, 1151, 1085, 1009, 852, 742, 687 cm–1. 
HRMS (DART) m/z: Calcd for C18H23N2O7S [M+H]+: 411.1226, Found: 411.1232. 
Methyl 2-(1-(naphthalen-1-ylsulfonyl)-2-oxo-1-azaspiro[4.5]decan-3-yl)acetate (2f): Reaction time 
was 4 d. A solid. Mp 151−152 °C. [α]D25 −3 (c 0.3, CHCl3). The ee was determined to be 42% by HPLC 
(Daicel CHIRALCEL OJ-H, hexane/EtOH = 4/1, 0.5 mL/min, 230 nm, minor 37 min, major 41 min. 1H 
NMR (400 MHz, CDCl3): δ 1.26–1.62 (m, 4H), 1.68–2.06 (m, 5H), 2.31 (dd, J = 17.4, 8.7 Hz, 1H), 2.60–
2.74 (m, 3H), 2.83–2.92 (m, 1H), 2.96–3.05 (m, 1H), 3.58 (s, 3H), 7.54–7.68 (m, 3H), 7.93 (d, J = 8.2 Hz, 
1H), 8.10 (d, J = 8.2 Hz, 1H), 8.43 (d, J = 7.8 Hz, 1H), 8.80 (d, J = 8.7 Hz, 1H). 13C NMR (100 MHz, 
CDCl3): δ 23.0, 24.2, 24.6, 33.9, 34.1, 36.2, 36.8, 37.9, 123.8, 124.1, 126.7, 128.1, 128.3, 128.4, 129.1, 
131.8, 133.9, 135.2, 171.6, 175.0. IR (KBr): 2929, 2862, 1724, 1594, 1507, 1436, 1335, 1305, 1198, 1158, 
1061, 1011, 907, 802, 769, 685 cm–1. HRMS (DART) m/z: Calcd for C22H26NO5S [M+H]+: 416.1532, 
Found: 416.1530. 
Methyl 2-(1-(naphthalen-2-ylsulfonyl)-2-oxo-1-azaspiro[4.5]decan-3-yl)acetate (2g): Reaction time 
was 3 d. A solid. Mp 148−150 °C. [α]D25 +3 (c 0.6, CHCl3). The ee was determined to be 51% by HPLC 
(Daicel CHIRALCEL OJ-H, hexane/EtOH = 4/1, 0.5 mL/min, 230 nm, major 38 min, minor 46 min). 1H 
NMR (400 MHz, CDCl3): δ 1.22–1.56 (m, 4H), 1.68–1.96 (m, 5H), 2.32 (dd, J = 16.9, 8.7 Hz, 1H), 2.56–
2.62 (m, 1H), 2.67–2.75 (m, 1H), 2.77 (dd, J = 16.9, 4.1 Hz, 1H), 2.85–3.02 (m, 2H), 3.61 (s, 3H), 7.62–
 
7.68 (m, 2H), 7.93–8.06 (m, 4H), 8.66 (s, 1H). 13C NMR (100 MHz, CDCl3): δ 22.8, 24.1, 24.5, 33.6, 
34.1, 36.5, 36.7, 37.8, 51.8, 69.8, 122.8, 127.4, 127.8, 128.8, 129.2, 129.6, 130.6, 131.7, 135.1, 136.4, 
171.6, 174.7. IR (KBr): 2926, 2862, 1734, 1593, 1441, 1342, 1301, 1171, 1150, 1071, 996, 907, 816, 749, 
657 cm–1. HRMS (DART) m/z: Calcd for C22H26NO5S [M+H]+: 416.1532, Found: 416.1532. 
(S)-Methyl 2-(2-oxo-1-tosyl-1-azaspiro[4.4]nonan-3-yl)acetate (2h): Reaction time was 4 d. A solid. 
Mp 110 °C. [α]D25 −6 (c 0.2, EtOH). The ee was determined to be 38% by HPLC (Daicel CHIRALCEL 
OJ-H, hexane/EtOH = 4/1, 0.5 mL/min, major 30 min, minor 58 min). 1H NMR (400 MHz, CDCl3): δ 
1.59−1.71 (m, 5H), 1.90−2.01 (m, 3H), 2.31 (ddd, J = 17.2, 8.7, 2.8 Hz, 1H), 2.37 (dd, J = 12.4, 8.7 Hz, 
1H), 2.43 (s, 3H), 2.81 (dd, J = 17.2, 4.0 Hz, 1H) 2.86−2.93 (m, 2H), 3.65 (s, 3H), 7.32 (d, J = 8.2 Hz, 
2H), 7.93 (d, J = 8.2 Hz, 2H). 13C NMR (100 MHz, CDCl3) δ 21.6, 23.8, 24.1, 33.8, 36.4, 37.4, 38.5, 42.8, 
51.8, 73.3, 128.4, 129.3, 136.4, 144.7, 171.7, 174.6. IR (KBr): 2938, 1727, 1595, 1457, 1350, 1313, 1156, 
1086, 1041, 815, 668 cm−1. HRMS (ESI) m/z: Calcd for C18H23NO5SNa [M+Na]+: 388.1189. Found: 
388.1199. 
(S)-Methyl 2-(2-oxo-1-tosyl-1-azaspiro[4.6]undecan-3-yl)acetate (2i): Reaction time was 5 d. A solid. 
Mp 160 °C. [α]D25 −3 (c 0.1, EtOH). The ee was determined to be 65% by HPLC (Daicel CHIRALCEL 
OJ-H, hexane/EtOH = 4/1, 0.5 mL/min, major 38 min, minor 43 min). 1H NMR (400 MHz, CDCl3): δ 
1.35−1.84 (m, 10H), 1.99 (dd, J = 13.7, 6.0 Hz, 1H), 2.31 (dd, J = 16.9, 8.7 Hz, 1H), 2.43 (s, 3H), 
2.48−2.56 (m, 1H), 2.55 (dd, J = 12.8, 8.7 Hz, 1H), 2.81 (dd, J = 16.9, 3.7 Hz, 1H), 2.87−2.95 (m, 2H), 
3.65 (s, 3H), 7.30 (d, J = 8.2 Hz, 2H), 7.94 (d, J = 8.2 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 21.1, 21.6, 
23.5, 27.0, 27.4, 34.2, 36.7, 38.3, 38.5, 39.7, 51.9, 72.8, 128.6, 129.2, 136.7, 144.6, 171.8, 174.3. IR 
(KBr): 2932, 1720, 1596, 1440, 1353, 1160, 1046, 824, 739, 707, 655 cm−1. HRMS (ESI) m/z: Calcd for 
C20H27NO5SNa [M+Na]+: 416.1502, Found: 416.1489. 
 (S)-Methyl 2-(5,5-dimethyl-2-oxo-1-tosylpyrrolidin-3-yl)acetate (2j): Reaction time was 7 d. A solid. 
Mp 140 °C. [α]D25 +1 (c 0.3, EtOH). The ee was determined to be 55% by HPLC (Daicel CHIRALCEL 
OJ-H, hexane/i-PrOH = 20/1, 0.5 mL/min, 230 nm, major 108 min, minor 136 min). 1H NMR (400 MHz, 
CDCl3): δ 1.57−1.64 (m, 1H), 1.59 (s, 3H), 1.67 (s, 3H), 2.19 (dd, J = 12.4, 8.7 Hz, 1H), 2.26 (dd, J = 
16.9, 8.7 Hz, 1H), 2.36 (s, 3H), 2.75 (dd, J = 16.9, 4.1 Hz, 1H), 2.83−2.92 (m, 1H), 3.57 (s, 3H), 7.24 (d, 
J = 8.2 Hz, 2H), 7.87 (d, J = 8.2 Hz, 2H). 13C NMR (100 MHz, CDCl3): δ 21.7, 26.9, 29.5, 34.1, 37.1, 
42.5, 51.9, 65.0, 128.6, 129.3, 136.4, 144.7, 171.7, 174.2. IR (KBr): 2923, 1731, 1598, 1446, 1342, 1290, 
1159, 1091, 1038, 811, 673 cm−1. HRMS (ESI) m/z: Calcd for C16H21NO5SNa [M+Na]+: 362.1033. 
Found: 362.1022. 
(S)-Methyl 2-(2-oxo-5,5-diphenyl-1-tosylpyrrolidin-3-yl)acetate (2k): Reaction time was 5 d. A solid. 
Mp 101−103 °C. [α]D25 –13 (c 0.7, CHCl3). The ee was determined to be 52% by HPLC (Daicel 
CHIRALPAK IB, hexane/i-PrOH = 20/1, 0.5 mL/min, 230 nm, major 46 min, minor 43 min). 1H NMR 
 
(400 MHz, CDCl3): δ 2.22−2.32 (m, 1H), 2.29 (s, 3H), 2.49 (dd, J = 17.4, 7.3 Hz, 1H), 2.63−2.82 (m, 3H), 
3.52 (s, 3H), 7.01 (d, J = 8.2 Hz, 2H), 7.05−7.39 (m, 10H), 7.56 (d, J = 8.2 Hz, 2H). 13C NMR (100 MHz, 
CDCl3): δ 21.6, 33.2, 37.0, 46.5, 51.8, 75.5, 125.2, 127.68, 127.74, 127.8, 128.09, 128.13, 128.3, 128.5, 
128.7, 128.9, 129.6, 136.0, 141.0, 141.2, 144.6, 171.3, 174.4. IR (KBr): 2979, 1723, 1658, 1599, 1435, 
1325, 1154, 1093, 989, 816, 666 cm−1. HRMS (ESI) m/z: Calcd for C26H25NO5SNa [M+Na]+: 486.1351, 
Found: 486.1367. 
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